KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Precigen (PGEN) EBIT (2016 - 2025)

Precigen (PGEN) has disclosed EBIT for 14 consecutive years, with -$21.7 million as the latest value for Q4 2025.

  • Quarterly EBIT rose 24.02% to -$21.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$110.5 million through Dec 2025, up 18.16% year-over-year, with the annual reading at -$110.5 million for FY2025, 18.16% up from the prior year.
  • EBIT for Q4 2025 was -$21.7 million at Precigen, up from -$34.5 million in the prior quarter.
  • The five-year high for EBIT was -$7.6 million in Q3 2022, with the low at -$60.8 million in Q2 2024.
  • Average EBIT over 5 years is -$25.4 million, with a median of -$22.4 million recorded in 2022.
  • The sharpest move saw EBIT surged 64.64% in 2022, then crashed 188.07% in 2024.
  • Over 5 years, EBIT stood at -$21.9 million in 2021, then grew by 0.34% to -$21.8 million in 2022, then tumbled by 57.01% to -$34.2 million in 2023, then grew by 16.68% to -$28.5 million in 2024, then rose by 24.02% to -$21.7 million in 2025.
  • According to Business Quant data, EBIT over the past three periods came in at -$21.7 million, -$34.5 million, and -$31.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.